Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo‐controlled multicentre trial

BACKGROUND AND AIMS: Incomplete microscopic colitis (MCi) is a subtype of microscopic colitis (MC). Budesonide is recommended as a first‐line treatment for MC. However, randomised trials on efficacy of treatment in MCi are missing. We therefore performed a randomised, placebo‐controlled trial to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Münch, Andreas, Mihaly, Emese, Nagy, Ferenc, Madisch, Ahmed, Kupčinskas, Juozas, Miehlke, Stephan, Bohr, Johan, Bouma, Gerd, Guardiola, Jordi, Belloc, Blanca, Shi, Chunliang, Aust, Daniela, Mohrbacher, Ralf, Greinwald, Roland, Munck, Lars Kristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435258/
https://www.ncbi.nlm.nih.gov/pubmed/34414678
http://dx.doi.org/10.1002/ueg2.12131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435258/
https://www.ncbi.nlm.nih.gov/pubmed/34414678
http://dx.doi.org/10.1002/ueg2.12131

Ejemplares similares